Onena Medicines Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Investors
-
15
Onena Medicines General Information
Description
Developer of an antibody drug discovery platform designed to reprogram cancer cells to treat advanced cancers, centered around proprietary artificial intelligence. The company's platform designs custom antibodies with high selectivity and specificity linked to proprietary cellular reprogramming lab assays, its drugs modulate activities of a novel set of growth factors called dual smad inhibiting protein dips, thought to drive the growth and spread of cancer, enabling physicians to get access to novel drugs in areas of unmet medical needs.
Contact Information
Website
www.onenameds.comCorporate Office
- Hegenheimermattweg 167A
- Switzerland Innovation Park Basel Area
- 4123 Allschwil
- Switzerland
Corporate Office
- Hegenheimermattweg 167A
- Switzerland Innovation Park Basel Area
- 4123 Allschwil
- Switzerland
Onena Medicines Timeline
Onena Medicines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC | 26-Mar-2025 | Completed | Pre-Clinical Trials | |||
| 12. Early Stage VC | 04-Dec-2023 | Cancelled | Pre-Clinical Trials | |||
| 11. Early Stage VC | 31-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 31-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 9. Accelerator/Incubator | 27-May-2022 | Completed | Pre-Clinical Trials | |||
| 8. Accelerator/Incubator | 11-May-2022 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 01-Apr-2022 | Completed | Product In Beta Test | |||
| 6. Early Stage VC | 01-Oct-2021 | Completed | Product In Beta Test | |||
| 5. Accelerator/Incubator | 02-Jun-2020 | $273K | Completed | Product In Beta Test | ||
| 4. Early Stage VC | 01-Jun-2020 | $273K | $273K | Completed | Product In Beta Test |
Onena Medicines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Onena Medicines Comparisons
Industry
Financing
Details
Onena Medicines Competitors (8)
One of Onena Medicines’s 8 competitors is Incendia Therapeutics, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Incendia Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| FoRx Therapeutics | Venture Capital-Backed | Basel, Switzerland | ||||
| HiberCell | Venture Capital-Backed | Roseville, MN | ||||
| Absci | Formerly VC-backed | Vancouver, WA | ||||
| Inhibitec | Accelerator/Incubator Backed | Santander, Spain |
Onena Medicines Patents
Onena Medicines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4182475-A2 | Antibodies against lefty proteins | Pending | 17-Jul-2020 | ||
| US-20240368259-A1 | Antibodies against lefty proteins | Pending | 17-Jul-2020 | ||
| WO-2022013613-A2 | Antibodies against lefty proteins | Inactive | 17-Jul-2020 | ||
| WO-2022013613-A3 | Antibodies against lefty proteins | Inactive | 17-Jul-2020 | ||
| WO-2022013613-A8 | Antibodies against lefty proteins | Inactive | 17-Jul-2020 | C07K16/22 |
Onena Medicines Signals
Onena Medicines Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Olive Venture Partners | Venture Capital | Minority | ||
| Plug and Play | Accelerator/Incubator | Minority | ||
| Avanteca Partners | Other | Minority | ||
| Bic Gipuzkoa | Accelerator/Incubator | |||
| EUREKA Network | Accelerator/Incubator |
Onena Medicines FAQs
-
When was Onena Medicines founded?
Onena Medicines was founded in 2019.
-
Where is Onena Medicines headquartered?
Onena Medicines is headquartered in Allschwil, Switzerland.
-
What is the size of Onena Medicines?
Onena Medicines has 9 total employees.
-
What industry is Onena Medicines in?
Onena Medicines’s primary industry is Drug Discovery.
-
Is Onena Medicines a private or public company?
Onena Medicines is a Private company.
-
What is Onena Medicines’s current revenue?
The current revenue for Onena Medicines is .
-
How much funding has Onena Medicines raised over time?
Onena Medicines has raised $2.47M.
-
Who are Onena Medicines’s investors?
Olive Venture Partners, Plug and Play, Avanteca Partners, Bic Gipuzkoa, and EUREKA Network are 5 of 15 investors who have invested in Onena Medicines.
-
Who are Onena Medicines’s competitors?
Incendia Therapeutics, FoRx Therapeutics, HiberCell, Absci, and Inhibitec are some of the 8 competitors of Onena Medicines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process